ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "Arial" (31)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Treosulfan (L01AB02) 2 products WHO-DDD  
L IP  Trecondi 1 g 114.23140.6510 %Lyophilisate: Treosulfanum 1 gIdeogen AGA / SL
L IP  Trecondi 5 g 548.76613.2510 %Lyophilisate: Treosulfanum 5 gIdeogen AGA / SL
Topotecan (L01CE01) 3 products WHO-DDD  
L IP  Topotecan Accord 1 mg 68.1590.5510 %Concentrate for infusion: Topotecanum 1 mg/mlAccord Healthcare AGA / SL / SG
L IP  Topotecan Accord 4 mg 242.89280.5510 %Concentrate for infusion: Topotecanum 4mg / 4mlAccord Healthcare AGA / SL / SG
L IP  Topotecan Accord 4 mg51209.371331.7010 %Concentrate for infusion: Topotecanum 4mg / 4mlAccord Healthcare AGA / SL / SG
Bevacizumab (L01FG01) 14 products WHO-DDD  
LSIPIPCI Avastin 100 mg/4 mlDurchstechflasche(n)270.48309.8010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlRoche Pharma
(Schweiz) AG
A / SL / SO
LSIPIPCI Avastin 400 mg/16 mlDurchstechflasche(n)1034.261136.8510 %Concentrate for infusion: Bevacizumabum 400mg / 16mlRoche Pharma
(Schweiz) AG
A / SL / SO
L IP  Abevmy 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlMedius AGA / SL / SG
L IP  Abevmy 400 mg/16 ml 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mlMedius AGA / SL / SG
L IP  Bevacizumab-Teva 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlTeva Pharma AGA / SL / SG
L IP  Bevacizumab-Teva 400
mg/16 ml
 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mlTeva Pharma AGA / SL / SG
L IP  MVASI 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlAmgen Switzerland AGA / SL / SG
L IP  MVASI 400 mg/16 ml 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mlAmgen Switzerland AGA / SL / SG
L IP  Oyavas 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlSpirig HealthCare AGA / SL / SG
L IP  Oyavas 400 mg/16 ml 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mlSpirig HealthCare AGA / SL / SG
L IP  Vegzelma 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mliQone Healthcare
Switzerland SA
A / SL / SG
L IP  Vegzelma 400 mg/16 ml 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mliQone Healthcare
Switzerland SA
A / SL / SG
L IP  Zirabev 100 mg/4 ml 216.38254.3010 %Concentrate for infusion: Bevacizumabum 100mg / 4mlPfizer AGA / SL / SG
L IP  Zirabev 400 mg/16 ml 827.41924.6010 %Concentrate for infusion: Bevacizumabum 400mg / 16mlPfizer AGA / SL / SG
Mirvetuximab Soravtansine (L01FX26) 1 products WHO-DDD  
L IP  ELAHERE 100 mg/20 ml 3106.013394.4010 %Concentrate for infusion: Mirvetuximabum Soravtansinum 100mg / 20mlAbbVie AGA / SL
Rucaparib (L01XK03) 6 products WHO-DDD  
L IPCI Rubraca 200 mg601823.351999.4010 %Coated tablets: Rucaparibum 200 mgmmpharm GmbHA / SL
L IPCI Rubraca 200 mg1203646.703982.4010 %Coated tablets: Rucaparibum 200 mgmmpharm GmbHA / SL
L IPCI Rubraca 250 mg602279.192495.1510 %Coated tablets: Rucaparibum 250 mgmmpharm GmbHA / SL
L IPCI Rubraca 250 mg1204558.384973.9510 %Coated tablets: Rucaparibum 250 mgmmpharm GmbHA / SL
L IPCI Rubraca 300 mg602735.032990.9510 %Coated tablets: Rucaparibum 300 mgmmpharm GmbHA / SL
L IPCI Rubraca 300 mg1205470.065920.1010 %Coated tablets: Rucaparibum 300 mgmmpharm GmbHA / SL
Topotecan (L01XX17) 5 products WHO-DDD DrugBank.ca 
L IPCI Hycamtin 0.25 mg10 Capsule(s)137.40165.8510 %Capsules: TopotecanumSandoz
Pharmaceuticals AG
A / SL
L IPCI Hycamtin 1 mg10 Capsule(s)549.59614.1510 %Capsules: Topotecanum 1 mgSandoz
Pharmaceuticals AG
A / SL
  IP  Hycamtin 1 mgDurchstechflasche(n)75.7298.30k.A.Lyophilisate: Topotecanum 1 mgSandoz
Pharmaceuticals AG
A
  IP  Hycamtin 4 mgDurchstechflasche(n)269.88308.25k.A.Lyophilisate: Topotecanum 4 mgSandoz
Pharmaceuticals AG
A
  IP  Hycamtin 4 mg5 Durchstechflasche(n)1343.741469.55k.A.Lyophilisate: Topotecanum 4 mgSandoz
Pharmaceuticals AG
A
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home